• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COL7A1/PI3K/AKT轴调控胆管癌的进展。

The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma.

作者信息

Ma Yang, Zhang Yanfang, Chen Fangfang, Liu Sihua, Wang Dongdong, Lu Zheng, Zhang Dengyong, Liang Rui

机构信息

Department of General Surgery, The First Affiliated Hospital of BengBu Medical College, NO. 287, Changhuai Road, Longzihu district, Bengbu, 233000, Anhui, China.

出版信息

Heliyon. 2024 Sep 7;10(18):e37361. doi: 10.1016/j.heliyon.2024.e37361. eCollection 2024 Sep 30.

DOI:10.1016/j.heliyon.2024.e37361
PMID:39309925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11415666/
Abstract

BACKGROUND

The role and molecular mechanisms of collagen type VII (COL7A1) in cholangiocarcinoma (CCA) remain unknown.

METHODS

We analyzed the expression of COL7A1 in CCA and its relationship with patient prognosis using bioinformatic techniques. Expression levels of COL7A1 in CCA cells and tissues were detected using reverse transcription-quantitative PCR, western blotting, and immunohistochemistry. The effects of COL7A1 expression on the proliferation, migration, and invasion of CCA cells were assessed using CCK-8, colony formation, and Transwell assays. Bioinformatics and luciferase reporter gene assays were performed to examine the binding of KLF4 to COL7A1, and cytological experiments further verified the role of KLF4 in regulating the CCA phenotype through COL7A1. Xenograft mouse models were established to investigate the effects of COL7A1 on CCA tumor growth .

RESULTS

CCA tissues exhibited higher COL7A1 expression than normal bile duct tissues. There was no significant correlation between high or low COL7A1 expression and the survival time of patients with CCA. COL7A1 knockdown inhibited CCA cell proliferation, migration, and invasion. Furthermore, COL7A1 knockdown suppressed the activation of the PI3K/AKT signaling pathway. KLF4 can bind to COL7A1 and regulate COL7A1 expression, which in turn regulates the PI3K/AKT signaling pathway and impacts the proliferation and metastasis of CCA cells.

CONCLUSION

Our findings suggest that KLF4 regulates CCA cell proliferation, migration, and invasion via the COL7A1/PI3K/AKT axis.

摘要

背景

VII型胶原蛋白(COL7A1)在胆管癌(CCA)中的作用及分子机制尚不清楚。

方法

我们使用生物信息学技术分析了COL7A1在CCA中的表达及其与患者预后的关系。采用逆转录定量PCR、蛋白质免疫印迹法和免疫组织化学法检测COL7A1在CCA细胞和组织中的表达水平。使用CCK-8、集落形成和Transwell实验评估COL7A1表达对CCA细胞增殖、迁移和侵袭的影响。进行生物信息学和荧光素酶报告基因实验以检测KLF4与COL7A1的结合,细胞学实验进一步验证了KLF4通过COL7A1调节CCA表型的作用。建立异种移植小鼠模型以研究COL7A1对CCA肿瘤生长的影响。

结果

CCA组织中COL7A1表达高于正常胆管组织。COL7A1表达的高低与CCA患者的生存时间无显著相关性。COL7A1敲低抑制了CCA细胞的增殖、迁移和侵袭。此外,COL7A1敲低抑制了PI3K/AKT信号通路的激活。KLF4可与COL7A1结合并调节COL7A1表达,进而调节PI3K/AKT信号通路并影响CCA细胞的增殖和转移。

结论

我们的研究结果表明,KLF4通过COL7A1/PI3K/AKT轴调节CCA细胞的增殖、迁移和侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/60644611409d/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/bd916a8153e8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/c2d398de5eaa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/cf3dc6784db6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/14c4a3bc9d3a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/a477ad704725/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/8b03c2276400/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/60644611409d/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/bd916a8153e8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/c2d398de5eaa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/cf3dc6784db6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/14c4a3bc9d3a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/a477ad704725/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/8b03c2276400/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef09/11415666/60644611409d/gr7.jpg

相似文献

1
The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma.COL7A1/PI3K/AKT轴调控胆管癌的进展。
Heliyon. 2024 Sep 7;10(18):e37361. doi: 10.1016/j.heliyon.2024.e37361. eCollection 2024 Sep 30.
2
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.针对双皮质素样激酶 1 高表达的胆管癌患者,靶向 PI3K/AKT/mTOR 通路提供了一种有前景的治疗策略。
J Cancer Res Clin Oncol. 2024 Jul 9;150(7):342. doi: 10.1007/s00432-024-05875-3.
3
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.三结构域蛋白 59(TRIM59)的敲低通过 PI3K/AKT/mTOR 信号通路抑制胆管癌细胞的增殖。
Gene. 2019 May 25;698:50-60. doi: 10.1016/j.gene.2019.02.044. Epub 2019 Feb 27.
4
HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.HSDL2 敲低通过 P53/SLC7A11 轴抑制铁死亡促进胆管癌的进展。
World J Surg Oncol. 2023 Sep 18;21(1):293. doi: 10.1186/s12957-023-03176-6.
5
Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.通过抑制 PTEN/PI3K/Akt 通路,雷公藤红素抑制胆管癌细胞增殖、侵袭和迁移从而发挥抗肿瘤活性。
Cancer Med. 2020 Jan;9(2):783-796. doi: 10.1002/cam4.2719. Epub 2019 Nov 26.
6
Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.Tip60通过PI3k-AKT抑制胆管癌的增殖和转移。
Cell Physiol Biochem. 2018;50(2):612-628. doi: 10.1159/000494183. Epub 2018 Oct 11.
7
LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.长链非编码 RNA NEAT1 通过 miR-186-5p/PTP4A1 轴促进胆管癌中的细胞增殖、迁移和侵袭。
Kaohsiung J Med Sci. 2021 May;37(5):379-391. doi: 10.1002/kjm2.12354. Epub 2021 Jan 27.
8
YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis.YY1激活EMI2并通过PI3K/Akt信号轴促进胆管癌进展。
Cancer Cell Int. 2021 Dec 21;21(1):699. doi: 10.1186/s12935-021-02328-6.
9
miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.miR-181b-5p 通过靶向 PARK2 经 PTEN/PI3K/AKT 信号通路促进胆管癌的进展。
Biochem Genet. 2022 Feb;60(1):223-240. doi: 10.1007/s10528-021-10084-5. Epub 2021 Jun 24.
10
ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation.ARHGAP21 参与胆管癌的致癌机制:基于生物信息学分析和实验验证的研究。
Medicina (Kaunas). 2023 Jan 10;59(1):139. doi: 10.3390/medicina59010139.

引用本文的文献

1
Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma.抗癌肽在肝内胆管癌类器官模型中的应用及机制
Sci Rep. 2025 Jul 2;15(1):22870. doi: 10.1038/s41598-025-06127-1.
2
Integrative Machine Learning and Bioinformatics Approach for Identifying Key Biomarkers in Gallbladder Cancer Diagnosis and Progression.用于识别胆囊癌诊断和进展关键生物标志物的综合机器学习与生物信息学方法
IET Syst Biol. 2025 Jan-Dec;19(1):e70022. doi: 10.1049/syb2.70022.

本文引用的文献

1
KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT.KLF4 通过负向调控 GDF15 和磷酸化 AKT 抑制肝门部胆管癌的增殖。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8659. Epub 2023 Nov 8.
2
USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.USP1 通过去泛素化 PARP1 来防止其蛋白酶体降解,从而促进胆管癌的进展。
Cell Death Dis. 2023 Oct 11;14(10):669. doi: 10.1038/s41419-023-06172-6.
3
KLF4 regulates skeletal muscle development and regeneration by directly targeting P57 and Myomixer.
KLF4 通过直接靶向 P57 和 Myomixer 调节骨骼肌发育和再生。
Cell Death Dis. 2023 Sep 18;14(9):612. doi: 10.1038/s41419-023-06136-w.
4
Development of potent antibody drug conjugates against ICAM1 cancer cells in preclinical models of cholangiocarcinoma.在胆管癌临床前模型中开发针对ICAM1癌细胞的强效抗体药物偶联物。
NPJ Precis Oncol. 2023 Sep 16;7(1):93. doi: 10.1038/s41698-023-00447-z.
5
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Eur J Surg Oncol. 2025 Feb;51(2):107064. doi: 10.1016/j.ejso.2023.107064. Epub 2023 Sep 9.
6
Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa.营养不良性大疱性表皮松解症中皮肤鳞状细胞癌发生过程中的VII型胶原蛋白缺乏
J Invest Dermatol. 2023 Nov;143(11):2108-2119. doi: 10.1016/j.jid.2023.05.024. Epub 2023 Jun 14.
7
Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.胆汁外泌体 miR-182/183-5p 通过靶向 HPGD 增加 PGE2 的生成,从而增加胆管癌细胞干性和进展。
Hepatology. 2024 Feb 1;79(2):307-322. doi: 10.1097/HEP.0000000000000437. Epub 2023 May 5.
8
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.欧洲肝脏研究学会-国际肝脏癌症协会《肝内胆管癌管理临床实践指南》。
J Hepatol. 2023 Jul;79(1):181-208. doi: 10.1016/j.jhep.2023.03.010. Epub 2023 Apr 20.
9
CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.CS-iCCA,一种新的基于临床的肝内胆管癌分期系统:建立和外部验证。
Am J Gastroenterol. 2023 Dec 1;118(12):2173-2183. doi: 10.14309/ajg.0000000000002258. Epub 2023 Mar 20.
10
Editing via RNA -Splicing in RDEB-Derived Skin Equivalents.通过 RNA 剪接编辑 RDEB 衍生皮肤等效物。
Int J Mol Sci. 2023 Feb 22;24(5):4341. doi: 10.3390/ijms24054341.